Literature DB >> 15214978

The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas.

Paul Park1, William F Chandler, Ariel L Barkan, John J Orrego, John A Cowan, Kent A Griffith, Christina Tsien.   

Abstract

OBJECTIVE: Radiotherapy after aggressive surgical resection of nonfunctional macroadenoma (NFA) of the pituitary remains controversial. Historically, immediate postoperative radiotherapy has been recommended to decrease risk of recurrence. With the availability of high-resolution imaging, most neurosurgeons now withhold radiation until recurrence. There is relatively little evidence to support this practice, however. This study reviews postoperative results in a large number of patients with NFA, the majority of whom did not undergo prophylactic radiation.
METHODS: Of the 258 patients who underwent surgery from 1979 to 1999 for NFA, medical records were available for 176. Forty-four patients were treated with immediate postoperative radiotherapy after tumor resection, and the remaining 132 patients were followed up with serial imaging studies and treated with radiotherapy only when a recurrence was documented by follow-up imaging.
RESULTS: Patients in the group that received immediate postoperative radiotherapy at time of initial diagnosis and surgery did not differ significantly with respect to age or sex from those in the group that was observed. Five- and 10-year recurrence rates were 2.3 and 2.3%, respectively, for patients who received immediate postoperative radiotherapy, as compared with 15.2 and 50.5%, respectively, for patients who were followed up and did not receive radiotherapy unless there was evidence of recurrence or progression. No patient had symptomatic recurrence in the group that was observed if consistent follow-up was performed. Of the 26 patients who received radiotherapy at time of tumor recurrence or progression, 18 had adequate follow-up, and in all cases, the tumors either remained stable or regressed.
CONCLUSION: Withholding radiotherapy after a high-percentage resection of NFA leads to a higher recurrence rate, but it avoids exposing all patients to the risks of radiation. Deferring radiotherapy for patients with complete or near-complete resection seems to be a safe and prudent approach, as our data suggest that recurrences may be detected early with high-resolution imaging and treated effectively with radiation at time of recurrence. Therefore, immediate postoperative radiotherapy may be eliminated for patients with complete or near complete resection of NFA and who agree to undergo close follow-up for a long period.

Entities:  

Mesh:

Year:  2004        PMID: 15214978     DOI: 10.1227/01.neu.0000126885.71242.d7

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  36 in total

Review 1.  Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options.

Authors:  P D Delgado-López; J Pi-Barrio; M T Dueñas-Polo; M Pascual-Llorente; M C Gordón-Bolaños
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

Review 2.  Optimal management of non-functioning pituitary adenomas.

Authors:  Yona Greenman; Naftali Stern
Journal:  Endocrine       Date:  2015-07-16       Impact factor: 3.633

3.  The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study.

Authors:  Paul D Brown; Miran Blanchard; Krishan Jethwa; Kelly D Flemming; Cerise A Brown; Robert W Kline; Debra J Jacobson; Jennifer St Sauver; Bruce E Pollock; Yolanda I Garces; Scott L Stafford; Michael J Link; Dana Erickson; Robert L Foote; Nadia N I Laack
Journal:  Neurooncol Pract       Date:  2014-03

4.  Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas: results from a 26-year experience.

Authors:  Jinxiu Yu; Yanli Li; Tingting Quan; Xi Li; Chao Peng; Jiamin Zeng; Shunyao Liang; Minyi Huang; Yong He; Yinhui Deng
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

5.  Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity.

Authors:  Hiromitsu Iwata; Kengo Sato; Koshi Tatewaki; Naoki Yokota; Mitsuhiro Inoue; Yoshimi Baba; Yuta Shibamoto
Journal:  Neuro Oncol       Date:  2011-06-10       Impact factor: 12.300

6.  A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome.

Authors:  Lukui Chen; William L White; Robert F Spetzler; Bainan Xu
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

Review 7.  Radiotherapy of nonfunctioning and gonadotroph adenomas.

Authors:  Andrew A Kanner; Benjamin W Corn; Yona Greenman
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 8.  Management of nonfunctioning pituitary tumors: radiotherapy.

Authors:  Giuseppe Minniti; John Flickinger; Barbara Tolu; Sergio Paolini
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

9.  Debulking surgery of pituitary adenoma as a strategy to facilitate definitive stereotactic radiosurgery.

Authors:  Neil Forster; Ronald Warnick; Vinita Takiar; Luke Pater; John Breneman
Journal:  J Neurooncol       Date:  2018-02-15       Impact factor: 4.130

10.  The role of the le fort I maxillotomy in the management of incompletely resected pituitary macroadenomas.

Authors:  Bruce Mickey; Leslie Hutchins; Edward Ellis
Journal:  Skull Base       Date:  2007-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.